Folic Acid Deficiency

FDA approves generic drug for a rare genetic condition

FDA approves leucovorin to treat rare cerebral folate deficiency

The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate deficiency, a rare disorder.

· 1d

FDA approves generic drug for a rare genetic condition, but not for autism

· 1d · on MSN

FDA approves new use of synthetic vitamin B9 — but not for autism symptoms

· 1d

FDA Finds Little Evidence That a Drug Touted by Trump Can Help People With Autism

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that th...

· 1d

US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms

· 1d

FDA contradicts Trump admin, declines to approve generic drug for autism

· 15h

FDA OKs drug for rare brain disorder

"There is no evidence to say that leucovorin will help most people with autism, and there's certainly no evidence to say it's safe," said Dr. Alycia Halladay of the Autism Science Foundation, in an in...

· 16h

FDA Pushes Back on RFK Jr.’s Claims About Autism Drug — Report

· 1d

Trump administration does about face on autism treatment

17h

FDA approves GSK’s Wellcovorin for cerebral folate deficiency

FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.

Fierce Pharma

FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an exciting therapy that may benefit large numbers of children who suffer from autism” during a White House press conference,

Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin

Six months ago, the federal government loudly proclaimed the likely benefits of an existing drug called leucovorin for treating autism. Now that proclamation has officially turned into a whimper. On Tuesday,

Clinical Advisor

Leucovorin Tablets Approved for Cerebral Folate Transport Deficiency

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological complications.